🔎 Trials Near Me

Akèy › Kansè vejik › Kansas › Kansas City

Etid klinik pou Kansè vejik nan Kansas City, KS

12 etid pou Kansè vejik ap chèche patisipan nan sit nan ak bò kote Kansas City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

Ap rekriteFaz 2
  • University of Kansas Cancer Center, Kansas City
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT06770582

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Veteran Administration Eastern Kansas Healthcare, Leavenworth · 21 mi lwen
Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069

A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

Ap rekriteFaz 1
  • The University of Kansas Hospital Cambridge North Tower A, Kansas City
  • The University of Kansas Hospital, Kansas City
  • The University of Kansas Medical Center Medical Office Building, Kansas City
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07206225

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

Ap rekriteFaz 3
  • University of Kansas Cancer Center, Kansas City
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT07097142

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Ap rekriteFaz 1/2
  • The University of Kansas Cancer Center, Kansas City
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT05592626

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

Ap rekriteFaz 1/2
  • University of Kansas Medical Center, Kansas City
Laj 18 ak plis · Tout sèks · Mizajou Aug 7, 2026 · NCT04752722

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Ap rekriteFaz 1
  • The University of Kansas Hospital, Kansas City
  • The University of Kansas Medical Center Medical Office Building, Kansas City
  • University of Kansas Hospital Cambridge North Tower A, Kansas City
  • ak 1 plis
Laj 18 ak plis · Tout sèks · Mizajou Jul 6, 2026 · NCT04389632

Metabolism Evaluation Through Resting Indirect Calorimetry in Bladder Cancer (METRICS)

Ap rekriteEtid obsèvasyon
  • University of Kansas Medical Center, Kansas City
  • University of Kansas Medical Center, Kansas City
Laj 18 ak plis · Tout sèks · Mizajou Mar 20, 2026 · NCT06721260

Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers

Ap rekriteEtid obsèvasyon
  • University of Kansas Medical Center, Kansas City
Laj 18 ak plis · Tout sèks · Mizajou Mar 10, 2026 · NCT03413982

Blue Light Cystoscopy With Cysview® Registry

Ap rekriteEtid obsèvasyon
  • University of Kansas Medical Center, Kansas City
Laj 18 ak plis · Tout sèks · Mizajou Dec 18, 2025 · NCT02660645

Intravenous Ascorbate Plus Gemcitabine/Carboplatin: A Novel and Cost-Effective Alternative With Evident Efficacy in Patients With Muscle Invasive Bladder Cancer

Ap rekriteFaz 2
  • The University of Kansas Cancer Center, Kansas City
Laj 18 ak plis · Tout sèks · Mizajou Feb 20, 2025 · NCT06493370

LaserEn: SOLTIVE™ Thulium Laser Fiber En Bloc Resection of Bladder Tumors

Ap rekriteEtid obsèvasyon
  • University of Kansas Medical Center, Kansas City
Laj 18 ak plis · Tout sèks · Mizajou Oct 16, 2024 · NCT04979156

Etid Kansè vejik nan lòt vil

Lòt etid nan Kansas City

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.